Who Paid My Doc
Kengreal
Drug Cardiovascular
NDC 10122-620-10
General payments
$3,076,988
Research payments
$366,693
Through program year 2025, $3,076,988 in general payments and $366,693 in research payments were reported against Kengreal (Cardiovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $477,822 | 3,176 |
| 2024 | General | $821,681 | 3,519 |
| 2023 | General | $564,657 | 3,656 |
| 2023 | Research | $241,925 | 85 |
| 2022 | General | $369,233 | 4,926 |
| 2021 | General | $183,963 | 4,657 |
| 2021 | Research | $100,168 | 36 |
| 2020 | General | $105,766 | 627 |
| 2019 | General | $553,866 | 5,154 |
| 2019 | Research | $24,600 | 10 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 69 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
25,715 general · 131 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.